Wikipedia -WSS

Wikipedia

author：explore 2025-09-27 21:27:40 - browse：43228

STAT's Casey Ross (left) and Kimberly Powell, NVIDIA's vice president for healthcare at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug?

The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today.

Kimberly Powell, vice president of healthcare for NVIDIA, pointed to an increase in investigational new drug applications filed with the Food and Drug Administration that cite AI, as well as an uptick in early-stage readouts from clinical trials, as evidence of progress. Some of the recent readouts, Powell said, show that what’s going into Phase 1 clinical trials is more successful.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Study says nonprofit hospitals fall short in charity care spending

focus

WSS

Three issues to watch in global health in 2024

Biotech reporter’s notebook: A sunnier mood at JPM 2024

As JPM 2024 winds down, some health tech firms project optimism

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

There's no autism epidemic. It's an autism diagnosis epidemic

Eliminate the waiting period for sterilization covered by Medicaid

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Apple is now the first public company to be valued at $3 trillion

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Duchenne breakthrough therapy leaves behind pioneering families

There's no autism epidemic. It's an autism diagnosis epidemic

Moonlake's readout produced a cash windfall. Risks remain

The SUPPORT Act is critical to fighting the opioid crisis

Malaria cases in Florida and Texas: Here’s what you need to know

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Wikipedia

Readout LOUD podcast: live from JPM 2024

Fauci’s Covid grilling leads GOP to weigh foreign research rules

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Idaho abortion case may prompt more restrictions in other states

There's no autism epidemic. It's an autism diagnosis epidemic

States should stop sabotaging methadone treatment reform

entertainment

leisure time

focus

hotspot